Mizuho Securities Reiterates Buy on Allergan (AGN) Following a 4Q Earnings Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. CRWV

Go back to Mizuho Securities Reiterates Buy on Allergan (AGN) Following a 4Q Earnings Beat

Allergan Reports Exceptional Fourth Quarter 2015 Continuing Operations Performance with 74% Increase in Net Revenue to $4.2 Billion and 33% Growth in Non-GAAP Diluted EPS to $3.41

February 22, 2016 7:30 AM EST

DUBLIN, Feb. 22, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) reported exceptional performance with net revenue from continuing operations increasing 74 percent to $4.2 billion for the quarter ended December 31, 2015, compared to $2.4 billion in the fourth quarter 2014. On a non-GAAP basis, diluted earnings per share from continuing operations increased 33 percent to $3.41 for the fourth quarter 2015, compared to $2.57 in the fourth quarter 2014. On a full year basis, net revenue from continuing operations was up 124 percent compared to 2014 and Non-GAAP EPS from continuing operations increased 78 percent to $13.43. GAAP loss from continuing operations per diluted share for the fourth... More

Aegon Reports Net Income of EUR 478 Million in the Fourth Quarter of 2015

February 19, 2016 1:54 AM EST

THE HAGUE, the Netherlands, February 19, 2016 /PRNewswire/ --

Underlying earnings before tax amount to EUR 486 million  Underlying earnings impacted by lower earnings in US Net income increases to EUR 478 million, driven by net recoveries and lower fair value losses Return on equity of 8.3% Record sales driven by fee-based deposit businesses  Strong growth in asset management drives gross deposits up 63% to EUR 22.3 billion; net deposits increase to EUR 2.8 billion New life insurance sales decline... More